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Abstract 
   Synthetic Biology is the new engineering-based approach to biology that includes applications of 
designing complex biological devices. At present, it is not yet clear what will emerge as the defining 
principles of Synthetic Biology. One proposed approach is to build Synthetic Biology around the classical 
engineering principles of standardization, modularity/decoupling and abstraction/modeling to facilitate 
component-based design. In this article we suggest and discuss an alternative paradigm, which we call 
High-throughput Biologically Optimized Search Engineering (HT-BOSE). Stemming from directed 
evolution, in HT-BOSE the focal point is a biological knowledge based rational optimization of the search 
process in the space of device design possibilities. The HT-BOSE approach may also be relevant in other 
contexts and we briefly highlight how it could be applicable to the development of multi-drug cocktails 
in a biomedical setting. 
 
Introduction 
   Genetic engineering, defined as the purposeful manipulation of a single gene within an organism, is 
today a commonplace technology (1). A greater challenge is moving from single-gene manipulation, to 
the engineering of complex biological devices that incorporate multiple interacting functions. The goal 
at present is creation of a full-fledged engineering field with living matter as its substrate. This hopeful 
engineering field is most often called Synthetic Biology (2). 
   Every engineering field is characterized by its own set of canonical principles. These principles are 
distinct insofar as they are determined by different substrates of study, engineering objectives and 
relevant governing physical laws. Nonetheless, all major engineering fields are based on an overarching 
common design philosophy (2). Sustained by the three concepts of standardization of parts, 
modularity/decoupling and abstraction/modeling, this Classical Engineering Design (CED) approach 
allows the construction of complex engineering devices with manageable, limited trial and error tuning. 
This is remarkable, as a very large number of parts and an even larger number of interactions between 
those parts would normally render the successful implementation of a device all but impossible. 
   There is an ongoing major effort to build a CED foundation for Synthetic Biology (3). For instance, a 
registry of standard biological parts has been created (4). At present it contains thousands of distinct 
entries, with varying degrees of quality control for each part. This foundation already allows 
undergraduate students in a yearly summer Synthetic Biology competition to, in mere weeks, 
successfully build working devices of a few parts (5). However, the ultimate goal of Synthetic Biology is 
not being able to put together elementary devices in days or weeks, but rather to enable the 
engineering of complex devices. 
   In Synthetic Biology unwanted interactions are inherently difficult to predict and avoid (6). This is due 
to the molecular/chemical nature of the interactions and the unfeasibility of physically 
compartmentalizing every interaction. As the number of parts in a device grows, the number of such 
pernicious interactions will grow even faster. We argue this scaling poses a major hurdle for traditional 
CED component-based approaches and potentially renders CED an ineffective  approach to engineer 
complex biological devices. For a device involving dozens of parts, the amount of fine tuning required 
would be unworkable. 
   A distinct conceptual view of engineering is attained by considering Design Space (DS) - the space of all 
possible device designs. Given the time to try out every possible design, it would be a mere formality to 
select the best design to the task at hand. Naturally, this is not feasible due to the very high 
dimensionality of DS. CED provides a way of immediately placing ourselves close to a working design, 
which can then be hopefully reached via some fine-tuning. However, as explained above, we argue that 
for complex biological devices, CED is not a good approach as in this case the large number of pernicious 
interactions will actually place us far from a functioning design. 
   The evolutionary histories of natural organisms trace paths in DS. This motivated the biological 
engineering technique of directed evolution (7). Directed evolution consists of performing alternating 
rounds of mutation and selection/screening with the intent of moving in DS towards a good design for 
the task at hand. It has been extensively applied to the engineering of enzymes (8), and more recently to 
the engineering of elementary biological devices (9). Nevertheless, so far it has not been possible to 
construct complex devices via directed evolution any more than it has been via CED. Directed evolution 
as a nonspecific statistical search technique in a very high-dimensional space of possibilities has not 
proven to be powerful enough. 
   We suggest that the future of Synthetic Biology lies in combining biological knowledge and directed 
evolution into a biologically-guided rational optimization of the DS search process. We designate this 
approach High-Throughput Biologically Optimized Search Engineering (HT-BOSE) and suggest it as a 
framework for designing biological devices. This article will focus on founding principles for HT-BOSE. In 
parallel, HT-BOSE will also require the development of appropriate technologies for its implementation, 
in particular for an increase in the throughput of the search process (10; 11; 12). We consider there are 
three foundational elements to an HT-BOSE approach, which we now discuss in turn: Search strategies, 
the Design Registry and fitness assays. 
 
Search strategies 
   We start by posing a streamlined version of the search problem in HT-BOSE. Given a particular aim for 
a device, every design in DS has an associated fitness score. The fitness of any given design is unknown, 
until the design is realized and assayed in some fashion. The objective is to find a high fitness design, 
under the constraint that a limited number of designs can be assayed. 
   If there is no knowledge at all of the structure of the fitness function over DS, then the strategy of 
randomly picking designs in DS for assaying is as good as any other search strategy. This is an instance of 
the principle that “there are no free-lunches in optimization” (13). 
   Now, it is clear that designs that differ by a single base pair in their encoding DNA tend to have 
correlated fitness, as they tend to be designs with modest differences. This DS functional structure 
enables the pursuit of the traditional hill-climbing search, i.e. directed evolution, based on point 
mutations (7). Namely, a search that is based on successive rounds of point mutation and selection of 
the best mutated design(s) as the starting point(s) for the next round. Naturally, this hill climbing 
towards a higher fitness design is a much more efficient strategy than random search. Nonetheless, 
mutation interactions can be nonlinear with regards to effect on fitness. For instance, a simultaneous 
mutation in multiple sites might be beneficial,  whereas the same mutations in isolation are not. As a 
result, many design improvements are unreachable via point mutation hill-climbing. In other words, 
point mutation hill-climbing is limited by local fitness optima. 
   Yet, there is a much richer DS functional structure than the one just described. For instance, there is 
DS functional structure at other length-scales. Knowledge of this additional biological structure can be 
explored to improve the hill-climbing search process. We start by describing optimization of the search 
process at a very different length-scale. 
 
Microbial consortia 
   Community level synergies between different microbial species often result in a consortium of 
microbes being more efficient than a single organism at fulfilling a desired task (14). As an example, 
microbial communities might be pertinent to biofuel production (15). In the context of consortia, a point 
in DS represents a potential Community Design (defined by a design being ascribed to each organism in 
the community). A community can be optimized by the point mutation search process previously 
described, with the point mutations being applied over all the microbes in the community. However, 
there is also DS functional structure at the level of what microbes constitute the community. Therefore, 
an additional way of hill-climbing in DS is via whole-microbe-at-a-time changes to the community 
composition. Note how this constitutes searching DS via jumps at a distinct length-scale that is much 
larger than point mutation changes. In a sense, swapping microbes can be viewed as a course-grained 
adjustment within DS, whereas point mutations can be viewed as a fine-grained adjustment. 
 
   Given the biological significance of genes, there is invariably DS functional structure at the level of 
what genes are present in an organism. Hill-climbing in DS at the gene length-scale, via whole-gene-at-a-
time changes to an organism, is therefore also pertinent. Gene length-scale changes would stand as an 
intermediate-grained adjustment compared to whole organism exchanges (course-grained) and genetic 
point mutations (fine-grained). 
   Recombination based techniques are widely used in the enzyme optimization context (16; 17). For this 
family of techniques, the hill-climbing in DS occurs via recombination of entire parts of proteins. The 
effectiveness of the method rests on the modular nature of proteins, that constitutes DS functional 
structure at yet another length-scale (18). 
   The examples above leverage generic DS functional structure. However, biological knowledge specific 
to the problem at hand can be invaluable. High-throughput genomic data collection and analysis can 
play an important role in this regard (19; 20; 21). As a case in point, many of these techniques yield 
functional networks of genes. Such networks embody DS functional structure information. Analogously 
to what happens with mutations, gene interactions can have a nonlinear effect on fitness. The 
simultaneous introduction of multiple genes in an organism might be beneficial, while the isolated 
introduction of any one of those same genes is not. Functional networks of genes enable hill-climbing 
strategies based on prioritizing specific multiple-genes-at-a-time changes to an organism. An otherwise 
unguided search at a multiple-genes-at-a-time-jumps length-scale would be generally unsuccessful, due 
to the volume of DS to be explored and the relative sparseness of worthy designs in DS. Functional 
networks at other biological levels may likewise be explored. 
   In CED, knowledge is often applied directly to the design of a device. It is not easy to acquire biological 
knowledge at the level of detail required for relevance in such a task. In HT-BOSE, biological knowledge 
is equally important. However, as shown, it is instead used to infer DS functional structure that enables 
a more efficient search process. We suggest this less demanding form of leveraging knowledge is more 
realistic for the complex biological setting and, in particular, may better match the typical detail-level of 
information generated by high-throughput approaches.  
   Ultimately, HT-BOSE will involve combining a diversity of hill-climbing strategies in a true multi-scale 
search process for engineering function. Figure 2 outlines how this could be implemented in practice. 
Now, a successful search in a very high-dimensional space, besides an efficient search strategy, requires 
an appropriate choice of where to start the search. We next discuss implications of this to an HT-BOSE 
approach to Synthetic Biology. 
 
Design Registry for HT-BOSE 
   In CED, engineering of a new device relies on combining and reusing existing parts. A good library of 
standardized parts, appropriately catalogued and characterized, is crucial to enable this. For engineering 
of devices via a search process, the counterpart is a good library of Seed Designs to serve as search 
starting points. Further, such a Design Registry should also be a source of the seed-parts required for the 
ensuing jumps-at-different-length-scales search strategies discussed in the previous section. 
   A seed likely close in DS to a design that fulfills the engineering objectives at hand has obvious 
advantages. An existing microbe that already nearly fulfills the new engineering objectives constitutes 
naturally a good starting point for modifications. However, the choice of ideal starting point is not 
always so clear. There may be no existing device already very close to fulfilling the desired engineering 
objectives. For example, the objectives may require a combination of traits of vastly different existing 
organisms. An important characteristic for a seed is that of flexibility. Some designs may not be practical 
engineering devices for any purpose and yet constitute excellent seeds. That is the case if the structure 
of DS is such that it is possible to hill-climb from them to a large diversity of useful designs. Again, from 
the versatile-community to the versatile-single gene, such flexible designs and design-parts are present 
at all levels. 
   In contrast to the versatile design, a design may be an excellent practical device for a given purpose 
and yet, live in a region of DS that makes it a not so good starting point for hill-climbing to a design that 
addresses any objective other than that one. A trade-off between specificity (in the sense of closeness 
to fulfilling the final desired objective) and versatility may have to be considered when choosing seeds 
for a search process. The successful selection of seeds will not be trivial and likely will require trial and 
error. It will constitute a major part of the process of engineering a new device via HT-BOSE. 
   The seed selection process will rest on information available in the Design Registry. A design entry in 
the Registry must, besides data on functional characteristics, record how that design was generated. 
When an existing design is used as a seed for subsequent designs, this must also be noted. Effectively, 
designs can have a forward phylogenetic history in addition to their backward phylogenetic history. 
Sliding along a phylogeny may allow in particular an adjustment of the specificity-flexibility trade-off in 
seed selection. 
   The complexity of the phylogenetic history of a design is compounded by the fact that the search 
strategies discussed do not necessarily lead to elementary relationships between designs. The search at 
different length-scales process creates devices that have received contributions from a multiplicity of 
sources, across a range of length-scales. The discovery of horizontal gene transfer has complicated 
natural phylogenetics, but a phylogenetics for designs resulting from HT-BOSE is likely to be even more 
complex. Developing an ontology that facilitates handling of all this information will be of essence, given 
the crucial role of seed selection in the HT-BOSE engineering approach. 
   In its early stages, a Design Registry for HT-BOSE should take maximum advantage of the enormous 
diversity of communities, microbes and genes that Nature already provides. In this regard, it stands to 
benefit greatly from large-scale metagenomic data collection efforts (22; 23). As new synthetic designs 
are engineered and added to the Design Registry, older entries gradually develop forward phylogenies. 
In due course, the more flexible designs and design-parts become apparent, making the Design Registry 
ever more valuable in facilitating the seed selection phase of HT-BOSE. 
   We have discussed seed designs, where DS search processes begin. We have also already addressed 
search strategies for generating designs to assay in subsequent rounds of a search process. It remains to 
focus on the third major element of an HT-BOSE approach to Synthetic Biology, the fitness scoring assay. 
 
Fitness assays 
   Fitness assaying is the process whereby select designs are assayed and assigned a fitness score. For HT-
BOSE, the assaying and fitness scoring should ideally be amenable to high-throughput implementation. 
The best designs, based on their scores, are then utilized by the search strategy to generate the next set 
of designs to fitness assay. Iteration of this procedure hopefully leads to hill-climbing in DS towards a 
design that accomplishes the engineering objective at hand. 
   The natural fitness assay to use is the one that assesses how well a design fulfills the desired 
engineering objective. Unfortunately, this straightforward assay choice may not necessarily succeed. 
When the designs being assayed are still far from accomplishing the desired engineering purpose, a 
fitness score based on proximity to satisfying that goal may lack the scoring resolution for differentiating 
between those designs. The designs may all appear equally bad at achieving the objective, therefore 
precluding hill-climbing via prioritization of the best ones. In such situations, the HT-BOSE approach 
requires devising a succession of transitional fitness assays. These transitional fitness assays must 
provide intermediate goals that are interspersed closely enough for adequate fitness scoring resolution 
to exist at all times. Biological insight must be used to ensure that fulfillment of the succeeding 
intermediate goals corresponds to getting progressively closer to a design that meets the final 
engineering goal. Successful transitional fitness assays are likely rather problem-specific and therefore 
their formulation constitutes one of the more challenging tasks in HT-BOSE. 
   A switch to hill-climbing under an alternative supporting fitness assay may be valuable in instances the 
search in DS gets trapped in a local optima with respect to the main (and ultimately relevant) fitness 
function. Again, the choice of a supporting fitness assay should rely on biological insight into the specific 
problem in question. An intelligent choice for the supporting fitness assay could greatly surpass the 
typical default option of random jumping in DS every time trapping in a local optima occurs. A 
particularly relevant characteristic for a supporting assay may be the ability to draw the search towards 
a more versatile region in DS, before hill-climbing of the main fitness function towards the ultimate goal 
is resumed. Note how the specificity-flexibility adjustment, previously mentioned in the context of seed 
design selection, is now occurring during the actual search, via alternating between the main and the 
supporting fitness assay. A case in point is the use of a thermostability assay as the supporting assay in 
enzyme optimization problems (24). 
   Dynamically, optimization under a single fitness function can be visualized as a straightforward 
monotonic hill-climb towards a local fitness peak. By comparison, optimization under alternating fitness 
functions can produce a much richer spectrum of dynamical behaviors. As the simplest example, 
periodic orbits are possible in this latter case. It will be interesting to further explore from a 
mathematical standpoint this class of switched dynamical systems. 
   We end this section with reminders related to two peculiarities of engineering in a biological context. 
First, synthetic biological devices must be engineered for evolutionary stability under the setting and 
time-scale on which they will function. Therefore the fitness assay must be formulated to properly 
assess the operationally relevant evolutionary end point of a design. Second, a fundamental premise for 
pursuing HT-BOSE is that unwanted biological interactions are inherently difficult to circumvent.  
Therefore the subject of any fitness assaying should be the full integrated device at all times. Unlike 
under a CED approach, it makes no sense to develop different parts of a device in isolation and combine 
them only at a later stage. 
   Although we have been discussing HT-BOSE solely in the context of Synthetic Biology, it is applicable to 
other problems involving search within a very large space of possibilities. In the next section, we 
highlight the relevance of HT-BOSE in a particular biomedical setting. 
 
HT-BOSE in medical drug discovery 
   Medical drug discovery has been dominated by the single compound, single molecular target, 
paradigm. However, many common diseases, such as cancer, diabetes, immune-inflammatory and 
cardio-vascular disorders are likely inherently system-level pathologies (25). There is a growing 
appreciation that trying to address such system-level disruptions via modulation of a single target is 
unnecessarily restrictive. Instead, the single drug magic-bullet could be beneficially replaced by the 
multi-compound drug cocktail, that synergistically acts at multiple points of the system (26; 27). But 
direct design of a drug cocktail is too difficult while, akin to the DS of Synthetic Biology, the Cocktail 
Space of a priori possible drug cocktails is too large for a blind exhaustive search. A credible alternative 
may be biologically rational optimization of the search process. The HT-BOSE approach thus becomes 
directly relevant to the drug cocktail discovery problem. As an elementary example, Drug Cocktail Space 
functional structure exists in the form of compounds that are co-present in natural organisms. Medically 
this is reflected in the oftentimes apparent more positive therapeutic effect of a traditional medicine 
natural product versus that of its purified, most significant compound in isolation (27). 
 
Final Remarks 
   We propose that applying biological knowledge to the rational optimization of a DS search process is 
the most appropriate paradigm for Synthetic Biology. We discussed an elementary foundation for this 
HT-BOSE approach. In particular, we indicated how in HT-BOSE biological knowledge would be 
leveraged: via appropriate choice of seed designs, search strategies (based on DS functional structure) 
and transitional and supporting fitness assays. Notably, the HT-BOSE approach underscores harnessing 
the unforeseeable, but likely plentiful and highly valuable, synergies possible between existing biological 
elements. 
   Although we stressed contrasts between the two, there is effectively a continuum from pure HT-BOSE 
to pure CED. Different Synthetic Biology problems will likely require approaches at different points 
within this spectrum, seldom at the two extremes. 
   Synthetic Biology and Systems Biology, if successful, will bring with them a greatly enhanced 
understanding of living organisms, through the ability to engineer them and the ability to predict their 
behavior (28; 29). Hopefully the power of this knowledge will lead to an ever greater respect and 
appreciation for the preciousness of Life (30; 31). 
  
 
 
 
Figure 1. The HT-Biologically Optimized Search Engineering approach to Synthetic Biology. 
Seed Designs: A Registry of Seed Designs provides starting points (seeds) for the search processes in Design Space. 
To facilitate seed selection, Registry records should include phylogenetic information on how designs were 
generated, as well as on what subsequent designs originated from them. Seed selection may involve considering the 
trade-off between closeness of a seed to fulfilling the desired engineering objective and versatility of the seed as a 
search starting point. Designs that show high versatility as search starting points are apparent in the design 
phylogenetic tree. Fitness assays: Fitness scores are assigned to designs tested in the fitness assay. If assayed 
designs are still too far from fulfilling the desired goal, an evaluation based on this fulfillment may be unable to 
differentiate between the designs. In such cases, a succession of transitional fitness assays associated with 
intermediate engineering goals must be employed. Search processes can also get trapped in local fitness optima. 
Alternating the main assay with a supporting assay may circumvent this problem. A supporting assay that draws the 
search towards a more flexible region of Design Space may prove particularly helpful. Search strategies: Biological 
data is seldom detailed enough to allow a direct design approach. Yet, it may permit inference of Design Space 
functional structure. Devising rational Design Space search strategies is then possible. In particular, Design Space 
functional structure at multiple length-scales should be explored. 
  
Figure 2. Outline of a microbial consortia optimization experiment. 
Multi-scale experimental implementation of HT-BOSE will utilize cellular, pathway and molecular/genetic 
experimental tools to parallel computational analyses. Different organisms can be screened and selected based 
upon favorable functional characteristics to define the initial composition of a Designer consortium. Each of the 
selected organisms can be modified by pathway engineering techniques to delete or add biochemical capabilities 
(Metabolic engineering). Molecular and genetic changes can be implemented through extended co-culturing of 
selected and/or engineered organisms to foster stable consortia using Adaptive laboratory evolution. 
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